

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neurotransmitter-gated ion channel clustering (GO:0072578) | 5.91114019 |
| 2 | presynaptic membrane assembly (GO:0097105) | 5.42462505 |
| 3 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.30699331 |
| 4 | synaptic vesicle maturation (GO:0016188) | 5.03274001 |
| 5 | presynaptic membrane organization (GO:0097090) | 4.89523887 |
| 6 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.76230602 |
| 7 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.67872406 |
| 8 | vocalization behavior (GO:0071625) | 4.51880529 |
| 9 | neuron cell-cell adhesion (GO:0007158) | 4.45763126 |
| 10 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.43459358 |
| 11 | postsynaptic membrane organization (GO:0001941) | 4.42923503 |
| 12 | glutamate secretion (GO:0014047) | 4.37465260 |
| 13 | synaptic vesicle exocytosis (GO:0016079) | 4.25902737 |
| 14 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.16455894 |
| 15 | cellular potassium ion homeostasis (GO:0030007) | 4.14447701 |
| 16 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 4.01640778 |
| 17 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.99099922 |
| 18 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.91095155 |
| 19 | protein localization to synapse (GO:0035418) | 3.89440212 |
| 20 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.89149647 |
| 21 | membrane depolarization during action potential (GO:0086010) | 3.67965984 |
| 22 | neurotransmitter secretion (GO:0007269) | 3.67291387 |
| 23 | response to histamine (GO:0034776) | 3.63517082 |
| 24 | long-term synaptic potentiation (GO:0060291) | 3.54410137 |
| 25 | startle response (GO:0001964) | 3.50992345 |
| 26 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.49609048 |
| 27 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.47937780 |
| 28 | NADH metabolic process (GO:0006734) | 3.45286774 |
| 29 | regulation of synaptic vesicle transport (GO:1902803) | 3.43441991 |
| 30 | succinate metabolic process (GO:0006105) | 3.42224197 |
| 31 | cerebellar granule cell differentiation (GO:0021707) | 3.42085668 |
| 32 | oxaloacetate metabolic process (GO:0006107) | 3.41313594 |
| 33 | neuron-neuron synaptic transmission (GO:0007270) | 3.36474959 |
| 34 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.34067626 |
| 35 | gamma-aminobutyric acid transport (GO:0015812) | 3.29787766 |
| 36 | serotonin metabolic process (GO:0042428) | 3.24372787 |
| 37 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.22657676 |
| 38 | cellular sodium ion homeostasis (GO:0006883) | 3.22060588 |
| 39 | transferrin transport (GO:0033572) | 3.20149534 |
| 40 | positive regulation of neurotransmitter transport (GO:0051590) | 3.19613671 |
| 41 | behavioral response to cocaine (GO:0048148) | 3.19490038 |
| 42 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.17424287 |
| 43 | potassium ion import (GO:0010107) | 3.14664414 |
| 44 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.13944350 |
| 45 | mechanosensory behavior (GO:0007638) | 3.13861953 |
| 46 | synaptic transmission, glutamatergic (GO:0035249) | 3.11566462 |
| 47 | detection of calcium ion (GO:0005513) | 3.10778994 |
| 48 | cardiac conduction (GO:0061337) | 3.10430001 |
| 49 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.09126225 |
| 50 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.09126225 |
| 51 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.06883553 |
| 52 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.06061774 |
| 53 | trivalent inorganic cation transport (GO:0072512) | 3.05030092 |
| 54 | ferric iron transport (GO:0015682) | 3.05030092 |
| 55 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.04643944 |
| 56 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 3.03924045 |
| 57 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.02179742 |
| 58 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.01839983 |
| 59 | glutamate receptor signaling pathway (GO:0007215) | 3.01079177 |
| 60 | positive regulation of synapse maturation (GO:0090129) | 3.00931878 |
| 61 | dicarboxylic acid catabolic process (GO:0043649) | 3.00547873 |
| 62 | potassium ion homeostasis (GO:0055075) | 2.96964448 |
| 63 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.95910124 |
| 64 | sodium ion export (GO:0071436) | 2.95380780 |
| 65 | locomotory exploration behavior (GO:0035641) | 2.91728344 |
| 66 | cell communication by electrical coupling (GO:0010644) | 2.91021215 |
| 67 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.90988789 |
| 68 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.89188848 |
| 69 | positive regulation of synapse assembly (GO:0051965) | 2.85454684 |
| 70 | neurotransmitter transport (GO:0006836) | 2.83875812 |
| 71 | regulation of membrane repolarization (GO:0060306) | 2.83757198 |
| 72 | negative regulation of appetite (GO:0032099) | 2.83519350 |
| 73 | negative regulation of response to food (GO:0032096) | 2.83519350 |
| 74 | regulation of postsynaptic membrane potential (GO:0060078) | 2.82015167 |
| 75 | regulation of glutamate secretion (GO:0014048) | 2.81861014 |
| 76 | multicellular organismal signaling (GO:0035637) | 2.81731137 |
| 77 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.80160739 |
| 78 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.78949215 |
| 79 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 2.78508987 |
| 80 | action potential (GO:0001508) | 2.77743301 |
| 81 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.76864884 |
| 82 | L-phenylalanine catabolic process (GO:0006559) | 2.75744245 |
| 83 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.75744245 |
| 84 | cardiac muscle cell action potential (GO:0086001) | 2.75571525 |
| 85 | regulation of cell communication by electrical coupling (GO:0010649) | 2.75549031 |
| 86 | neuronal action potential propagation (GO:0019227) | 2.75044016 |
| 87 | coenzyme catabolic process (GO:0009109) | 2.74715852 |
| 88 | cellular ketone body metabolic process (GO:0046950) | 2.74571937 |
| 89 | central nervous system myelination (GO:0022010) | 2.74528910 |
| 90 | axon ensheathment in central nervous system (GO:0032291) | 2.74528910 |
| 91 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.74381284 |
| 92 | L-amino acid import (GO:0043092) | 2.71277772 |
| 93 | regulation of neurotransmitter secretion (GO:0046928) | 2.71218577 |
| 94 | * regulation of female receptivity (GO:0045924) | 2.69880247 |
| 95 | regulation of synapse maturation (GO:0090128) | 2.69230119 |
| 96 | regulation of sodium ion transmembrane transport (GO:1902305) | 2.68924422 |
| 97 | regulation of neurotransmitter levels (GO:0001505) | 2.68387595 |
| 98 | positive regulation of synaptic transmission (GO:0050806) | 2.68329916 |
| 99 | neuronal action potential (GO:0019228) | 2.67559170 |
| 100 | negative regulation of dendrite development (GO:2000171) | 2.67058584 |
| 101 | positive regulation of membrane potential (GO:0045838) | 2.66868206 |
| 102 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.66448098 |
| 103 | transmission of nerve impulse (GO:0019226) | 2.66088040 |
| 104 | behavioral response to nicotine (GO:0035095) | 2.66028402 |
| 105 | positive regulation of sodium ion transport (GO:0010765) | 2.65657636 |
| 106 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.65156293 |
| 107 | glutamate metabolic process (GO:0006536) | 2.64204273 |
| 108 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.62960690 |
| 109 | tricarboxylic acid cycle (GO:0006099) | 2.60480614 |
| 110 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.58982512 |
| 111 | positive regulation of muscle hypertrophy (GO:0014742) | 2.58982512 |
| 112 | regulation of synaptic plasticity (GO:0048167) | 2.58974132 |
| 113 | membrane depolarization (GO:0051899) | 2.58424490 |
| 114 | behavioral defense response (GO:0002209) | 2.57037842 |
| 115 | behavioral fear response (GO:0001662) | 2.57037842 |
| 116 | auditory behavior (GO:0031223) | 2.56837959 |
| 117 | aromatic amino acid family catabolic process (GO:0009074) | 2.55226588 |
| 118 | proline transport (GO:0015824) | 2.53892991 |
| 119 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.53815221 |
| 120 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.52736332 |
| 121 | relaxation of cardiac muscle (GO:0055119) | 2.51699138 |
| 122 | positive regulation of potassium ion transport (GO:0043268) | 2.51025626 |
| 123 | high-density lipoprotein particle remodeling (GO:0034375) | 2.50142563 |
| 124 | cell communication involved in cardiac conduction (GO:0086065) | 2.49470129 |
| 125 | aspartate family amino acid catabolic process (GO:0009068) | 2.48169982 |
| 126 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.47967310 |
| 127 | L-phenylalanine metabolic process (GO:0006558) | 2.47967310 |
| 128 | fear response (GO:0042596) | 2.47836826 |
| 129 | cellular response to ammonium ion (GO:0071242) | 2.47149425 |
| 130 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.47107828 |
| 131 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.46505765 |
| 132 | relaxation of muscle (GO:0090075) | 2.45826626 |
| 133 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.45152291 |
| 134 | negative regulation of protein localization to cell surface (GO:2000009) | 2.44885849 |
| 135 | striatum development (GO:0021756) | 2.44726380 |
| 136 | membrane repolarization (GO:0086009) | 2.43929632 |
| 137 | regulation of neurotransmitter transport (GO:0051588) | 2.43770347 |
| 138 | sleep (GO:0030431) | 2.43354008 |
| 139 | calcium ion-dependent exocytosis (GO:0017156) | 2.43303887 |
| 140 | membrane assembly (GO:0071709) | 2.43131814 |
| 141 | neuromuscular synaptic transmission (GO:0007274) | 2.42951012 |
| 142 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.42824357 |
| 143 | indole-containing compound catabolic process (GO:0042436) | 2.42703952 |
| 144 | indolalkylamine catabolic process (GO:0046218) | 2.42703952 |
| 145 | tryptophan catabolic process (GO:0006569) | 2.42703952 |
| 146 | neurotransmitter uptake (GO:0001504) | 2.42558325 |
| 147 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.41843081 |
| 148 | bile acid biosynthetic process (GO:0006699) | 2.41684724 |
| 149 | synapse assembly (GO:0007416) | 2.40621952 |
| 150 | primary amino compound metabolic process (GO:1901160) | 2.40387690 |
| 151 | positive regulation of dendritic spine development (GO:0060999) | 2.39905608 |
| 152 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.39565539 |
| 153 | regulation of amino acid transport (GO:0051955) | 2.38126382 |
| 154 | sodium ion homeostasis (GO:0055078) | 2.37798276 |
| 155 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.36780468 |
| 156 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.36648514 |
| 157 | retinal cone cell development (GO:0046549) | 2.36290788 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.74393325 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.01715779 |
| 3 | TAF15_26573619_Chip-Seq_HEK293_Human | 3.03174575 |
| 4 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.73780437 |
| 5 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.60031331 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.53418667 |
| 7 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.35538323 |
| 8 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.28925716 |
| 9 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.26009609 |
| 10 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.21410312 |
| 11 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.17622124 |
| 12 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.10874524 |
| 13 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.09319957 |
| 14 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.08425440 |
| 15 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.03456295 |
| 16 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.99045806 |
| 17 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.99045806 |
| 18 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.98179751 |
| 19 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.97564410 |
| 20 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.96450251 |
| 21 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.95757314 |
| 22 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.94662559 |
| 23 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.90672158 |
| 24 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.89902668 |
| 25 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.89437470 |
| 26 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.88704031 |
| 27 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.83109576 |
| 28 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.79572103 |
| 29 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.75549522 |
| 30 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.73448112 |
| 31 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.71929141 |
| 32 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.71492885 |
| 33 | FUS_26573619_Chip-Seq_HEK293_Human | 1.69802047 |
| 34 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.68675953 |
| 35 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.66403390 |
| 36 | VDR_22108803_ChIP-Seq_LS180_Human | 1.66370914 |
| 37 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.60907471 |
| 38 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.59671746 |
| 39 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.59615286 |
| 40 | AR_25329375_ChIP-Seq_VCAP_Human | 1.58560525 |
| 41 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.58285461 |
| 42 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.57227819 |
| 43 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.51447961 |
| 44 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.51374427 |
| 45 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.50121691 |
| 46 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.47740054 |
| 47 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.47532495 |
| 48 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.46973478 |
| 49 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.41453467 |
| 50 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.41392665 |
| 51 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.39297850 |
| 52 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.38402981 |
| 53 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.37155531 |
| 54 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.36729663 |
| 55 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.36726499 |
| 56 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.35490681 |
| 57 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.34147273 |
| 58 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.29418045 |
| 59 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.27638746 |
| 60 | TCF4_23295773_ChIP-Seq_U87_Human | 1.27164769 |
| 61 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.24947883 |
| 62 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.22857049 |
| 63 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.22401532 |
| 64 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.21625029 |
| 65 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.21081705 |
| 66 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.21028040 |
| 67 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.20252576 |
| 68 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.18674975 |
| 69 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.18427627 |
| 70 | * RNF2_27304074_Chip-Seq_NSC_Mouse | 1.18042377 |
| 71 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16934112 |
| 72 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.16425353 |
| 73 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.15348431 |
| 74 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.14526763 |
| 75 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.14515193 |
| 76 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.13938433 |
| 77 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 1.13926894 |
| 78 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.13684007 |
| 79 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.12842637 |
| 80 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.12272741 |
| 81 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.12155395 |
| 82 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.10952751 |
| 83 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.10648313 |
| 84 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.10247835 |
| 85 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.09886372 |
| 86 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.09400399 |
| 87 | KDM2B_26808549_Chip-Seq_REH_Human | 1.09298498 |
| 88 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.08984758 |
| 89 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07435632 |
| 90 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.07166413 |
| 91 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.06918776 |
| 92 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.06691456 |
| 93 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.06691456 |
| 94 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.06533143 |
| 95 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.06085745 |
| 96 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.05147298 |
| 97 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.05147298 |
| 98 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.04513259 |
| 99 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.03123203 |
| 100 | * MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.02713192 |
| 101 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.02288850 |
| 102 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.01413759 |
| 103 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.00282114 |
| 104 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.99756690 |
| 105 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 0.99528319 |
| 106 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.99342455 |
| 107 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.99296474 |
| 108 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.99253863 |
| 109 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.99196356 |
| 110 | * AR_19668381_ChIP-Seq_PC3_Human | 0.98559763 |
| 111 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.98509376 |
| 112 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.98383455 |
| 113 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.98101752 |
| 114 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.95635557 |
| 115 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.92774360 |
| 116 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.92287962 |
| 117 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.89935422 |
| 118 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.89071828 |
| 119 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88209979 |
| 120 | TP53_16413492_ChIP-PET_HCT116_Human | 0.87809810 |
| 121 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87786498 |
| 122 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87311811 |
| 123 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.86835803 |
| 124 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.86153979 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 4.48597885 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 3.61980218 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 3.20516674 |
| 4 | MP0009745_abnormal_behavioral_response | 3.09066010 |
| 5 | MP0003635_abnormal_synaptic_transmissio | 3.02258375 |
| 6 | MP0001968_abnormal_touch/_nociception | 2.98249219 |
| 7 | MP0002736_abnormal_nociception_after | 2.91853262 |
| 8 | MP0009046_muscle_twitch | 2.78444965 |
| 9 | MP0008875_abnormal_xenobiotic_pharmacok | 2.70301592 |
| 10 | * MP0002064_seizures | 2.67749668 |
| 11 | MP0005365_abnormal_bile_salt | 2.65504934 |
| 12 | * MP0002063_abnormal_learning/memory/cond | 2.64451262 |
| 13 | MP0005360_urolithiasis | 2.61224101 |
| 14 | MP0005085_abnormal_gallbladder_physiolo | 2.56549841 |
| 15 | MP0002822_catalepsy | 2.54006055 |
| 16 | MP0002572_abnormal_emotion/affect_behav | 2.49762415 |
| 17 | * MP0002876_abnormal_thyroid_physiology | 2.45391065 |
| 18 | MP0004270_analgesia | 2.29300970 |
| 19 | MP0001501_abnormal_sleep_pattern | 2.11159856 |
| 20 | MP0002837_dystrophic_cardiac_calcinosis | 2.10657429 |
| 21 | MP0004145_abnormal_muscle_electrophysio | 2.06867884 |
| 22 | * MP0002272_abnormal_nervous_system | 2.04520164 |
| 23 | MP0002734_abnormal_mechanical_nocicepti | 2.04193965 |
| 24 | MP0001440_abnormal_grooming_behavior | 2.00658759 |
| 25 | MP0002735_abnormal_chemical_nociception | 1.96812320 |
| 26 | MP0003183_abnormal_peptide_metabolism | 1.96164651 |
| 27 | MP0001486_abnormal_startle_reflex | 1.94504979 |
| 28 | * MP0005646_abnormal_pituitary_gland | 1.94426562 |
| 29 | * MP0004130_abnormal_muscle_cell | 1.90134905 |
| 30 | MP0002067_abnormal_sensory_capabilities | 1.89603978 |
| 31 | MP0010329_abnormal_lipoprotein_level | 1.85011729 |
| 32 | MP0005670_abnormal_white_adipose | 1.68049067 |
| 33 | MP0006276_abnormal_autonomic_nervous | 1.62874894 |
| 34 | MP0003787_abnormal_imprinting | 1.59776099 |
| 35 | * MP0005551_abnormal_eye_electrophysiolog | 1.56163187 |
| 36 | MP0004924_abnormal_behavior | 1.49734635 |
| 37 | MP0005386_behavior/neurological_phenoty | 1.49734635 |
| 38 | MP0002557_abnormal_social/conspecific_i | 1.48923387 |
| 39 | MP0003195_calcinosis | 1.47229343 |
| 40 | MP0001984_abnormal_olfaction | 1.45047244 |
| 41 | MP0001188_hyperpigmentation | 1.40936183 |
| 42 | MP0001502_abnormal_circadian_rhythm | 1.40407642 |
| 43 | MP0005645_abnormal_hypothalamus_physiol | 1.39541633 |
| 44 | MP0004036_abnormal_muscle_relaxation | 1.36655185 |
| 45 | MP0004043_abnormal_pH_regulation | 1.29994698 |
| 46 | * MP0003879_abnormal_hair_cell | 1.29666510 |
| 47 | MP0001485_abnormal_pinna_reflex | 1.27864911 |
| 48 | MP0002909_abnormal_adrenal_gland | 1.25684955 |
| 49 | MP0001970_abnormal_pain_threshold | 1.25530774 |
| 50 | MP0004142_abnormal_muscle_tone | 1.22449716 |
| 51 | MP0005332_abnormal_amino_acid | 1.20260130 |
| 52 | MP0001764_abnormal_homeostasis | 1.17834810 |
| 53 | MP0002733_abnormal_thermal_nociception | 1.17579150 |
| 54 | MP0004215_abnormal_myocardial_fiber | 1.16381412 |
| 55 | MP0003633_abnormal_nervous_system | 1.15785757 |
| 56 | MP0003011_delayed_dark_adaptation | 1.14037032 |
| 57 | MP0008775_abnormal_heart_ventricle | 1.13470773 |
| 58 | MP0008569_lethality_at_weaning | 1.10610376 |
| 59 | MP0005535_abnormal_body_temperature | 1.10434312 |
| 60 | MP0008004_abnormal_stomach_pH | 1.10337141 |
| 61 | MP0003252_abnormal_bile_duct | 1.10059978 |
| 62 | MP0003690_abnormal_glial_cell | 1.09245999 |
| 63 | MP0003329_amyloid_beta_deposits | 1.05986435 |
| 64 | MP0001765_abnormal_ion_homeostasis | 1.05703206 |
| 65 | MP0002066_abnormal_motor_capabilities/c | 1.02859786 |
| 66 | MP0004147_increased_porphyrin_level | 1.00108176 |
| 67 | * MP0009780_abnormal_chondrocyte_physiolo | 0.99040107 |
| 68 | MP0002160_abnormal_reproductive_system | 0.98282995 |
| 69 | MP0001529_abnormal_vocalization | 0.98240740 |
| 70 | MP0002069_abnormal_eating/drinking_beha | 0.97943328 |
| 71 | MP0008872_abnormal_physiological_respon | 0.96596651 |
| 72 | MP0002184_abnormal_innervation | 0.96205092 |
| 73 | MP0001905_abnormal_dopamine_level | 0.95201065 |
| 74 | MP0002118_abnormal_lipid_homeostasis | 0.95002345 |
| 75 | MP0009697_abnormal_copulation | 0.94918516 |
| 76 | MP0000751_myopathy | 0.94094309 |
| 77 | MP0004019_abnormal_vitamin_homeostasis | 0.93084931 |
| 78 | MP0005167_abnormal_blood-brain_barrier | 0.92445523 |
| 79 | MP0002638_abnormal_pupillary_reflex | 0.91416028 |
| 80 | MP0001664_abnormal_digestion | 0.91112175 |
| 81 | * MP0000631_abnormal_neuroendocrine_gland | 0.90268887 |
| 82 | MP0003646_muscle_fatigue | 0.90209424 |
| 83 | * MP0001963_abnormal_hearing_physiology | 0.89993946 |
| 84 | MP0006292_abnormal_olfactory_placode | 0.89653423 |
| 85 | MP0000013_abnormal_adipose_tissue | 0.89471649 |
| 86 | MP0004084_abnormal_cardiac_muscle | 0.89377558 |
| 87 | MP0005187_abnormal_penis_morphology | 0.89275155 |
| 88 | * MP0002882_abnormal_neuron_morphology | 0.89162402 |
| 89 | MP0003631_nervous_system_phenotype | 0.88676391 |
| 90 | MP0008874_decreased_physiological_sensi | 0.87874049 |
| 91 | MP0004811_abnormal_neuron_physiology | 0.86870538 |
| 92 | MP0000778_abnormal_nervous_system | 0.85167641 |
| 93 | * MP0002229_neurodegeneration | 0.84213319 |
| 94 | MP0005620_abnormal_muscle_contractility | 0.83874552 |
| 95 | MP0004510_myositis | 0.83811268 |
| 96 | MP0005464_abnormal_platelet_physiology | 0.83436590 |
| 97 | * MP0003638_abnormal_response/metabolism_ | 0.82385620 |
| 98 | MP0004885_abnormal_endolymph | 0.81884960 |
| 99 | MP0002138_abnormal_hepatobiliary_system | 0.81827699 |
| 100 | MP0004134_abnormal_chest_morphology | 0.79794582 |
| 101 | MP0003868_abnormal_feces_composition | 0.79564447 |
| 102 | MP0005253_abnormal_eye_physiology | 0.79362218 |
| 103 | MP0005423_abnormal_somatic_nervous | 0.78773304 |
| 104 | MP0005084_abnormal_gallbladder_morpholo | 0.78300167 |
| 105 | MP0001666_abnormal_nutrient_absorption | 0.77986512 |
| 106 | MP0003122_maternal_imprinting | 0.77907996 |
| 107 | MP0001986_abnormal_taste_sensitivity | 0.77481798 |
| 108 | MP0006036_abnormal_mitochondrial_physio | 0.77190757 |
| 109 | MP0002971_abnormal_brown_adipose | 0.76696655 |
| 110 | MP0005448_abnormal_energy_balance | 0.76171332 |
| 111 | MP0000955_abnormal_spinal_cord | 0.75758710 |
| 112 | MP0001756_abnormal_urination | 0.74891725 |
| 113 | MP0002078_abnormal_glucose_homeostasis | 0.73203257 |
| 114 | MP0001177_atelectasis | 0.72959552 |
| 115 | MP0003137_abnormal_impulse_conducting | 0.72299270 |
| 116 | MP0005636_abnormal_mineral_homeostasis | 0.71794239 |
| 117 | MP0008877_abnormal_DNA_methylation | 0.69980145 |
| 118 | MP0004484_altered_response_of | 0.69792581 |
| 119 | MP0010386_abnormal_urinary_bladder | 0.68403032 |
| 120 | MP0005647_abnormal_sex_gland | 0.67690541 |
| 121 | MP0005394_taste/olfaction_phenotype | 0.66871615 |
| 122 | MP0005499_abnormal_olfactory_system | 0.66871615 |
| 123 | * MP0004085_abnormal_heartbeat | 0.66749214 |
| 124 | MP0001542_abnormal_bone_strength | 0.66717348 |
| 125 | MP0003806_abnormal_nucleotide_metabolis | 0.65911046 |
| 126 | * MP0000026_abnormal_inner_ear | 0.65225051 |
| 127 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.64913083 |
| 128 | MP0000230_abnormal_systemic_arterial | 0.64839311 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.00791987 |
| 2 | Hyperventilation (HP:0002883) | 6.92705071 |
| 3 | Epileptic encephalopathy (HP:0200134) | 5.52875201 |
| 4 | Atonic seizures (HP:0010819) | 5.16196367 |
| 5 | Febrile seizures (HP:0002373) | 4.63770981 |
| 6 | Focal seizures (HP:0007359) | 3.99082803 |
| 7 | Absence seizures (HP:0002121) | 3.75539142 |
| 8 | Dialeptic seizures (HP:0011146) | 3.52198787 |
| 9 | Ventricular fibrillation (HP:0001663) | 3.40341893 |
| 10 | Bundle branch block (HP:0011710) | 3.28448234 |
| 11 | Abnormality of binocular vision (HP:0011514) | 3.25425441 |
| 12 | Diplopia (HP:0000651) | 3.25425441 |
| 13 | Action tremor (HP:0002345) | 3.24310132 |
| 14 | Generalized tonic-clonic seizures (HP:0002069) | 3.13584356 |
| 15 | Broad-based gait (HP:0002136) | 3.11237840 |
| 16 | Pheochromocytoma (HP:0002666) | 2.99989676 |
| 17 | Blue irides (HP:0000635) | 2.89575679 |
| 18 | Increased circulating renin level (HP:0000848) | 2.88134763 |
| 19 | Syncope (HP:0001279) | 2.84988631 |
| 20 | Dysmetric saccades (HP:0000641) | 2.80197091 |
| 21 | Abnormal hair whorl (HP:0010721) | 2.77067256 |
| 22 | Protruding tongue (HP:0010808) | 2.76249316 |
| 23 | Progressive cerebellar ataxia (HP:0002073) | 2.70969638 |
| 24 | Epileptiform EEG discharges (HP:0011182) | 2.69441819 |
| 25 | Oligomenorrhea (HP:0000876) | 2.68744272 |
| 26 | Visual hallucinations (HP:0002367) | 2.65663231 |
| 27 | Neuroendocrine neoplasm (HP:0100634) | 2.62540506 |
| 28 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.58677722 |
| 29 | Decreased central vision (HP:0007663) | 2.58636626 |
| 30 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.56849838 |
| 31 | Hyperlipoproteinemia (HP:0010980) | 2.55521383 |
| 32 | Gaze-evoked nystagmus (HP:0000640) | 2.55376256 |
| 33 | Dysdiadochokinesis (HP:0002075) | 2.52829951 |
| 34 | Gait imbalance (HP:0002141) | 2.51270039 |
| 35 | Poor suck (HP:0002033) | 2.48814849 |
| 36 | Fair hair (HP:0002286) | 2.48170840 |
| 37 | Hemiparesis (HP:0001269) | 2.47730875 |
| 38 | Acute necrotizing encephalopathy (HP:0006965) | 2.46642015 |
| 39 | Prolonged partial thromboplastin time (HP:0003645) | 2.45563378 |
| 40 | Myokymia (HP:0002411) | 2.45562775 |
| 41 | Abnormal gallbladder physiology (HP:0012438) | 2.44708322 |
| 42 | Cholecystitis (HP:0001082) | 2.44708322 |
| 43 | Congenital primary aphakia (HP:0007707) | 2.42803609 |
| 44 | Medial flaring of the eyebrow (HP:0010747) | 2.42381546 |
| 45 | Decreased circulating renin level (HP:0003351) | 2.41700166 |
| 46 | Conjugated hyperbilirubinemia (HP:0002908) | 2.41381864 |
| 47 | Status epilepticus (HP:0002133) | 2.39659888 |
| 48 | Acute encephalopathy (HP:0006846) | 2.39241366 |
| 49 | Muscle fiber inclusion bodies (HP:0100299) | 2.39037197 |
| 50 | Intrahepatic cholestasis (HP:0001406) | 2.38608546 |
| 51 | Increased serum pyruvate (HP:0003542) | 2.38171994 |
| 52 | Abnormality of glycolysis (HP:0004366) | 2.38171994 |
| 53 | Renal cortical cysts (HP:0000803) | 2.36587594 |
| 54 | Abnormal social behavior (HP:0012433) | 2.36554837 |
| 55 | Impaired social interactions (HP:0000735) | 2.36554837 |
| 56 | Nephrogenic diabetes insipidus (HP:0009806) | 2.36422398 |
| 57 | Deep venous thrombosis (HP:0002625) | 2.35676688 |
| 58 | EEG with generalized epileptiform discharges (HP:0011198) | 2.33648065 |
| 59 | Intention tremor (HP:0002080) | 2.33277541 |
| 60 | Ankle clonus (HP:0011448) | 2.33209088 |
| 61 | Drooling (HP:0002307) | 2.31307653 |
| 62 | Excessive salivation (HP:0003781) | 2.31307653 |
| 63 | Heart block (HP:0012722) | 2.31213800 |
| 64 | Abnormal eating behavior (HP:0100738) | 2.30276662 |
| 65 | Impaired vibratory sensation (HP:0002495) | 2.30018803 |
| 66 | Poor eye contact (HP:0000817) | 2.29794200 |
| 67 | Xanthomatosis (HP:0000991) | 2.29016200 |
| 68 | Progressive macrocephaly (HP:0004481) | 2.27121673 |
| 69 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.27042009 |
| 70 | Gout (HP:0001997) | 2.26661677 |
| 71 | Vascular calcification (HP:0004934) | 2.25963617 |
| 72 | Polyphagia (HP:0002591) | 2.25376302 |
| 73 | Narrow nasal bridge (HP:0000446) | 2.24829073 |
| 74 | Menorrhagia (HP:0000132) | 2.24054574 |
| 75 | Hyporeflexia of lower limbs (HP:0002600) | 2.24009980 |
| 76 | Inability to walk (HP:0002540) | 2.23548533 |
| 77 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.21215859 |
| 78 | Abnormality of alanine metabolism (HP:0010916) | 2.21215859 |
| 79 | Hyperalaninemia (HP:0003348) | 2.21215859 |
| 80 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.19996668 |
| 81 | Spontaneous abortion (HP:0005268) | 2.18797733 |
| 82 | Hypsarrhythmia (HP:0002521) | 2.18595961 |
| 83 | Sensorimotor neuropathy (HP:0007141) | 2.18023129 |
| 84 | Cerebral edema (HP:0002181) | 2.16001562 |
| 85 | Ketosis (HP:0001946) | 2.15314049 |
| 86 | Agitation (HP:0000713) | 2.14499031 |
| 87 | Hyperkalemia (HP:0002153) | 2.13324615 |
| 88 | Ketoacidosis (HP:0001993) | 2.13227052 |
| 89 | Torticollis (HP:0000473) | 2.12522949 |
| 90 | Genetic anticipation (HP:0003743) | 2.11770592 |
| 91 | Nemaline bodies (HP:0003798) | 2.11353831 |
| 92 | Hypobetalipoproteinemia (HP:0003563) | 2.09741708 |
| 93 | Hyperglycinemia (HP:0002154) | 2.09479809 |
| 94 | Aplasia involving bones of the extremities (HP:0009825) | 2.08840054 |
| 95 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.08840054 |
| 96 | Aplasia of the phalanges of the hand (HP:0009802) | 2.08840054 |
| 97 | Central scotoma (HP:0000603) | 2.08315585 |
| 98 | Dysmetria (HP:0001310) | 2.07977302 |
| 99 | Congenital stationary night blindness (HP:0007642) | 2.07787051 |
| 100 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.07748313 |
| 101 | Exercise-induced myalgia (HP:0003738) | 2.07549584 |
| 102 | Sensory axonal neuropathy (HP:0003390) | 2.07213442 |
| 103 | Abnormality of the nasal septum (HP:0000419) | 2.05038150 |
| 104 | Abnormal atrioventricular conduction (HP:0005150) | 2.02182250 |
| 105 | Generalized hypopigmentation of hair (HP:0011358) | 2.01378904 |
| 106 | Confusion (HP:0001289) | 2.00940702 |
| 107 | Hypoalphalipoproteinemia (HP:0003233) | 2.00769255 |
| 108 | Incomplete penetrance (HP:0003829) | 2.00273331 |
| 109 | Metabolic alkalosis (HP:0200114) | 1.99775093 |
| 110 | Poor coordination (HP:0002370) | 1.98650754 |
| 111 | Scanning speech (HP:0002168) | 1.98426591 |
| 112 | Cardiovascular calcification (HP:0011915) | 1.96651733 |
| 113 | Resting tremor (HP:0002322) | 1.96611403 |
| 114 | Abnormal gallbladder morphology (HP:0012437) | 1.96142377 |
| 115 | Abnormality of renin-angiotensin system (HP:0000847) | 1.96017049 |
| 116 | Anxiety (HP:0000739) | 1.95583770 |
| 117 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.94877774 |
| 118 | Cholelithiasis (HP:0001081) | 1.93629920 |
| 119 | Sudden death (HP:0001699) | 1.93067014 |
| 120 | Abnormality of the renal cortex (HP:0011035) | 1.92256397 |
| 121 | Truncal ataxia (HP:0002078) | 1.92175844 |
| 122 | Hypolipoproteinemia (HP:0010981) | 1.91601808 |
| 123 | Congenital sensorineural hearing impairment (HP:0008527) | 1.91553798 |
| 124 | Hemiplegia (HP:0002301) | 1.91215721 |
| 125 | Hepatocellular necrosis (HP:0001404) | 1.90600441 |
| 126 | Chronic hepatic failure (HP:0100626) | 1.88917395 |
| 127 | Hyperaldosteronism (HP:0000859) | 1.86386694 |
| 128 | Abnormal EKG (HP:0003115) | 1.86293034 |
| 129 | Spastic gait (HP:0002064) | 1.85877675 |
| 130 | Oligodontia (HP:0000677) | 1.85187816 |
| 131 | Complement deficiency (HP:0004431) | 1.85131396 |
| 132 | Optic disc pallor (HP:0000543) | 1.84057243 |
| 133 | Calf muscle hypertrophy (HP:0008981) | 1.83255336 |
| 134 | Hyperactive renin-angiotensin system (HP:0000841) | 1.82028146 |
| 135 | Mitochondrial inheritance (HP:0001427) | 1.81918969 |
| 136 | Increased CSF lactate (HP:0002490) | 1.81558604 |
| 137 | Ventricular arrhythmia (HP:0004308) | 1.81357380 |
| 138 | Limb dystonia (HP:0002451) | 1.79878561 |
| 139 | Progressive inability to walk (HP:0002505) | 1.79172987 |
| 140 | Metabolic acidosis (HP:0001942) | 1.78532055 |
| 141 | Hyperglycinuria (HP:0003108) | 1.78156112 |
| 142 | Impaired smooth pursuit (HP:0007772) | 1.78147711 |
| 143 | Papilledema (HP:0001085) | 1.76502683 |
| 144 | Prolonged bleeding time (HP:0003010) | 1.76019577 |
| 145 | Focal dystonia (HP:0004373) | 1.75529969 |
| 146 | Generalized myoclonic seizures (HP:0002123) | 1.73642326 |
| 147 | Abnormality of potassium homeostasis (HP:0011042) | 1.73257841 |
| 148 | Cubitus valgus (HP:0002967) | 1.72641240 |
| 149 | Amblyopia (HP:0000646) | 1.71956712 |
| 150 | Prolonged QT interval (HP:0001657) | 1.70298833 |
| 151 | Myotonia (HP:0002486) | 1.69962359 |
| 152 | Hyperammonemia (HP:0001987) | 1.69685791 |
| 153 | Hepatic necrosis (HP:0002605) | 1.69541868 |
| 154 | Abnormality of the lower motor neuron (HP:0002366) | 1.69538717 |
| 155 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.69185155 |
| 156 | Abnormality of glycine metabolism (HP:0010895) | 1.69141593 |
| 157 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.69141593 |
| 158 | Failure to thrive in infancy (HP:0001531) | 1.67886431 |
| 159 | Absent speech (HP:0001344) | 1.67862845 |
| 160 | Postural instability (HP:0002172) | 1.67452032 |
| 161 | Osteomalacia (HP:0002749) | 1.66209144 |
| 162 | Megalencephaly (HP:0001355) | 1.65785372 |
| 163 | Polydipsia (HP:0001959) | 1.63122105 |
| 164 | Abnormal drinking behavior (HP:0030082) | 1.63122105 |
| 165 | Obstructive sleep apnea (HP:0002870) | 1.61573170 |
| 166 | Craniofacial dystonia (HP:0012179) | 1.59145748 |
| 167 | Hypomagnesemia (HP:0002917) | 1.58171393 |
| 168 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.57891788 |
| 169 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 1.55683903 |
| 170 | Short 1st metacarpal (HP:0010034) | 1.55683903 |
| 171 | Absent phalangeal crease (HP:0006109) | 1.55659868 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 7.75933450 |
| 2 | AKT3 | 3.44171258 |
| 3 | MAP2K7 | 3.22464399 |
| 4 | DAPK2 | 3.17544335 |
| 5 | EPHA4 | 2.96766708 |
| 6 | PHKG1 | 2.94602992 |
| 7 | NTRK3 | 2.85187121 |
| 8 | MAP3K4 | 2.76766253 |
| 9 | MAP3K12 | 2.60868633 |
| 10 | CCNB1 | 2.47182357 |
| 11 | OBSCN | 2.31561667 |
| 12 | DAPK1 | 2.18852966 |
| 13 | PRPF4B | 2.13823820 |
| 14 | PLK2 | 2.09388260 |
| 15 | CDK19 | 2.07359980 |
| 16 | MAP2K4 | 1.97630125 |
| 17 | SGK2 | 1.78905416 |
| 18 | TSSK6 | 1.77437040 |
| 19 | SIK3 | 1.61149342 |
| 20 | PDK4 | 1.55756292 |
| 21 | PDK3 | 1.55756292 |
| 22 | INSRR | 1.53318638 |
| 23 | OXSR1 | 1.53026466 |
| 24 | SGK494 | 1.50831499 |
| 25 | SGK223 | 1.50831499 |
| 26 | PRKCG | 1.46070039 |
| 27 | STK39 | 1.44137558 |
| 28 | GRK5 | 1.29847762 |
| 29 | SGK3 | 1.27082540 |
| 30 | MAP2K6 | 1.25776451 |
| 31 | MAPK7 | 1.19765672 |
| 32 | PAK3 | 1.19513375 |
| 33 | TAOK3 | 1.17454085 |
| 34 | MAPKAPK3 | 1.16831581 |
| 35 | PDK2 | 1.14645524 |
| 36 | CAMKK2 | 1.13266192 |
| 37 | MAPK12 | 1.12628228 |
| 38 | NTRK1 | 1.11756874 |
| 39 | MINK1 | 1.10481572 |
| 40 | NTRK2 | 1.08231661 |
| 41 | ERBB4 | 1.05846613 |
| 42 | WNK4 | 1.05340654 |
| 43 | UHMK1 | 1.04121497 |
| 44 | CAMK2A | 1.02517622 |
| 45 | PRKD3 | 1.01660275 |
| 46 | PRKCE | 1.01371640 |
| 47 | TNIK | 0.92870310 |
| 48 | NME1 | 0.91657643 |
| 49 | BMPR2 | 0.91457112 |
| 50 | LATS2 | 0.90986418 |
| 51 | MYLK | 0.88414223 |
| 52 | FRK | 0.86613711 |
| 53 | PIK3CA | 0.85687171 |
| 54 | MUSK | 0.85515533 |
| 55 | BRAF | 0.83433879 |
| 56 | CDK8 | 0.81619721 |
| 57 | TLK1 | 0.81346295 |
| 58 | PINK1 | 0.80666795 |
| 59 | BCKDK | 0.80072837 |
| 60 | BCR | 0.79988414 |
| 61 | CDK5 | 0.79601526 |
| 62 | ADRBK2 | 0.78503095 |
| 63 | NEK6 | 0.77346055 |
| 64 | STK38 | 0.77269014 |
| 65 | PTK2B | 0.76569541 |
| 66 | RIPK4 | 0.75012571 |
| 67 | TYRO3 | 0.74839237 |
| 68 | CAMK2B | 0.74782332 |
| 69 | MAPK13 | 0.73869535 |
| 70 | ADRBK1 | 0.69628697 |
| 71 | ERBB2 | 0.67499861 |
| 72 | SGK1 | 0.66343708 |
| 73 | CAMKK1 | 0.63954655 |
| 74 | CDK3 | 0.63766802 |
| 75 | MAP3K9 | 0.63649947 |
| 76 | KSR1 | 0.62282957 |
| 77 | MARK1 | 0.61825991 |
| 78 | GRK1 | 0.60748248 |
| 79 | PRKG1 | 0.60711927 |
| 80 | MAP4K2 | 0.60189675 |
| 81 | CAMK1G | 0.59999355 |
| 82 | SIK1 | 0.58827968 |
| 83 | PKN1 | 0.58803884 |
| 84 | WNK3 | 0.56903180 |
| 85 | DAPK3 | 0.54968158 |
| 86 | PRKCZ | 0.54578183 |
| 87 | DMPK | 0.54138054 |
| 88 | CAMK2G | 0.52641975 |
| 89 | MAPKAPK5 | 0.52574903 |
| 90 | PRKACG | 0.51894033 |
| 91 | PRKAA1 | 0.50449169 |
| 92 | PAK6 | 0.50300597 |
| 93 | YES1 | 0.50151964 |
| 94 | FER | 0.50099977 |
| 95 | TNK2 | 0.49753698 |
| 96 | CSNK1G2 | 0.49000501 |
| 97 | PRKAA2 | 0.48476138 |
| 98 | DYRK1A | 0.48354403 |
| 99 | RIPK1 | 0.48338521 |
| 100 | CAMK2D | 0.47849708 |
| 101 | MAP3K7 | 0.46939613 |
| 102 | CSNK1E | 0.46600209 |
| 103 | KSR2 | 0.45826974 |
| 104 | PIK3CG | 0.43026972 |
| 105 | PRKCH | 0.41987571 |
| 106 | CSNK1A1 | 0.41085619 |
| 107 | MAPK10 | 0.40979619 |
| 108 | PRKACA | 0.40372145 |
| 109 | CDK18 | 0.40016374 |
| 110 | CAMK1 | 0.39631965 |
| 111 | BMPR1B | 0.39489936 |
| 112 | CSNK1D | 0.39107857 |
| 113 | MAP3K2 | 0.38200322 |
| 114 | FGFR2 | 0.37071280 |
| 115 | ARAF | 0.36939487 |
| 116 | SIK2 | 0.36873172 |
| 117 | GRK7 | 0.36201392 |
| 118 | WNK1 | 0.35951160 |
| 119 | PRKCA | 0.35282755 |
| 120 | PRKD1 | 0.34831667 |
| 121 | CAMK1D | 0.34445149 |
| 122 | STK11 | 0.34329088 |
| 123 | MAP3K6 | 0.33161713 |
| 124 | MAP2K1 | 0.32543355 |
| 125 | PDPK1 | 0.32435312 |
| 126 | PRKCB | 0.32317237 |
| 127 | RPS6KA3 | 0.31848230 |
| 128 | CDK15 | 0.31747021 |
| 129 | PDK1 | 0.31625104 |
| 130 | MKNK2 | 0.30941720 |
| 131 | CAMK4 | 0.30734744 |
| 132 | FGR | 0.30377556 |
| 133 | STK16 | 0.29714679 |
| 134 | RPS6KB1 | 0.28981418 |
| 135 | FES | 0.28504057 |
| 136 | CDK14 | 0.28348229 |
| 137 | PHKG2 | 0.27765813 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.41410632 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.08527137 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.08250150 |
| 4 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.75245165 |
| 5 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.54880047 |
| 6 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.20325345 |
| 7 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.16766550 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.98463385 |
| 9 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.93023307 |
| 10 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.90424089 |
| 11 | GABAergic synapse_Homo sapiens_hsa04727 | 1.84749547 |
| 12 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.81196436 |
| 13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.80205319 |
| 14 | Phototransduction_Homo sapiens_hsa04744 | 1.77242575 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.76319443 |
| 16 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.73893444 |
| 17 | Morphine addiction_Homo sapiens_hsa05032 | 1.71241114 |
| 18 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.64534099 |
| 19 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.59704232 |
| 20 | Olfactory transduction_Homo sapiens_hsa04740 | 1.57820597 |
| 21 | Circadian entrainment_Homo sapiens_hsa04713 | 1.55712557 |
| 22 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.44980454 |
| 23 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.43946319 |
| 24 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.43734273 |
| 25 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.42227157 |
| 26 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.41941418 |
| 27 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.29969085 |
| 28 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.29714182 |
| 29 | Long-term potentiation_Homo sapiens_hsa04720 | 1.28688617 |
| 30 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.27753321 |
| 31 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.25540917 |
| 32 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.22757327 |
| 33 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.21166595 |
| 34 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.19708525 |
| 35 | Insulin secretion_Homo sapiens_hsa04911 | 1.19129503 |
| 36 | Taste transduction_Homo sapiens_hsa04742 | 1.17681837 |
| 37 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.17557827 |
| 38 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.17256000 |
| 39 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.13953156 |
| 40 | Peroxisome_Homo sapiens_hsa04146 | 1.12525487 |
| 41 | Salivary secretion_Homo sapiens_hsa04970 | 1.11679653 |
| 42 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.09157727 |
| 43 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.07631806 |
| 44 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.07060726 |
| 45 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.06928196 |
| 46 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.03613485 |
| 47 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.03555400 |
| 48 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.01662715 |
| 49 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.00996099 |
| 50 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.00061445 |
| 51 | Carbon metabolism_Homo sapiens_hsa01200 | 0.99405789 |
| 52 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.97128112 |
| 53 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.96202382 |
| 54 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.95585657 |
| 55 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.95409544 |
| 56 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.95265996 |
| 57 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.95070716 |
| 58 | Renin secretion_Homo sapiens_hsa04924 | 0.93190160 |
| 59 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.92937468 |
| 60 | Bile secretion_Homo sapiens_hsa04976 | 0.90998778 |
| 61 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.88321899 |
| 62 | Gap junction_Homo sapiens_hsa04540 | 0.87948708 |
| 63 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.86173016 |
| 64 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.85348658 |
| 65 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.85049959 |
| 66 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.84869401 |
| 67 | Long-term depression_Homo sapiens_hsa04730 | 0.84209916 |
| 68 | Retinol metabolism_Homo sapiens_hsa00830 | 0.84153601 |
| 69 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.83344540 |
| 70 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.83005640 |
| 71 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.79416716 |
| 72 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.77668144 |
| 73 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.76379964 |
| 74 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.75832098 |
| 75 | Histidine metabolism_Homo sapiens_hsa00340 | 0.74381082 |
| 76 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.73315828 |
| 77 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.72998658 |
| 78 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.71918670 |
| 79 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.70840096 |
| 80 | Circadian rhythm_Homo sapiens_hsa04710 | 0.69640016 |
| 81 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.69364039 |
| 82 | Mineral absorption_Homo sapiens_hsa04978 | 0.69176466 |
| 83 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.68911347 |
| 84 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.68688287 |
| 85 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.68446291 |
| 86 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.68071724 |
| 87 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.67871651 |
| 88 | Cocaine addiction_Homo sapiens_hsa05030 | 0.66872838 |
| 89 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.64740769 |
| 90 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.63908893 |
| 91 | Alzheimers disease_Homo sapiens_hsa05010 | 0.63752613 |
| 92 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.63620893 |
| 93 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.62684846 |
| 94 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.62483211 |
| 95 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.60630338 |
| 96 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.60036001 |
| 97 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.57508612 |
| 98 | Platelet activation_Homo sapiens_hsa04611 | 0.54497979 |
| 99 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.54293315 |
| 100 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.52187738 |
| 101 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.51963052 |
| 102 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.50902155 |
| 103 | Parkinsons disease_Homo sapiens_hsa05012 | 0.49467952 |
| 104 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.49087317 |
| 105 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.48286583 |
| 106 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.47593198 |
| 107 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.47323838 |
| 108 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.47316048 |
| 109 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.47094900 |
| 110 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.46883342 |
| 111 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.44959080 |
| 112 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.44421520 |
| 113 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.44289679 |
| 114 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.43115893 |
| 115 | ABC transporters_Homo sapiens_hsa02010 | 0.42573370 |
| 116 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.42518996 |
| 117 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.42510931 |
| 118 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.42385494 |
| 119 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.42206969 |
| 120 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.40080435 |
| 121 | Phagosome_Homo sapiens_hsa04145 | 0.38212367 |
| 122 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.38155247 |
| 123 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.37755625 |
| 124 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.37628559 |

